Molecular Design of New Inhibitors of Peroxidase Activity of Cytochrome c/Cardiolipin Complexes: Fluorescent Oxadiazole-Derivatized Cardiolipin

被引:22
作者
Borisenko, G. G. [4 ]
Kapralov, A. A. [1 ,2 ]
Tyurin, V. A. [1 ,2 ]
Maeda, A. [1 ,2 ]
Stoyanovsky, D. A. [3 ]
Kagan, V. E. [1 ,2 ]
机构
[1] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA
[4] Res Inst Physicochem Med, Moscow, Russia
关键词
D O I
10.1021/bi801507s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interaction of a mitochondria-specific anionic phospholipid, cardiolipin (CL), with an intermembrane protein, cytochrome c (cyt c), yields a peroxidase complex. During apoptosis, the complex induces accumulation of CL oxidation products that are essential for detachment of cyt c from the mitochondrial membrane, induction of permeability transition, and release of proapoptotic factors into the cytosol. Therefore, suppression of the peroxidase activity and prevention of CL oxidation may lead to discovery of hew antiapoptotic drugs. Here, we report a new approach to regulate the cyt c peroxidase activity by using modified CL with an oxidizable and fluorescent 7-nitro-2,1,3-benzoxadiazole (NBD) moiety (NBD-CL). We demonstrate that NBD-CL forms high-affinity complexes with cyt c and blocks cyt c-catalyzed oxidation of several peroxidase substrates, cyt c self-oxidation, and, most importantly, inhibits cyt c-dependent oxidation of polyunsaturated tetralinoleoyl CL (TLCL) and accumulation of TLCL hydroperoxides. Electrospray ionization mass spectrometry and fluorescence analysis revealed that oxidation and cleavage of the NBD moiety of NBD-CL underlie the inhibition mechanism. We conclude that modified CL combining a nonoxidizable monounsaturated trioleoyl CL with a C-12-NBD fragment undergoes a regiospecific oxidation thereby representing a novel inhibitor of cyt c peroxidase activity.
引用
收藏
页码:13699 / 13710
页数:12
相关论文
共 63 条
  • [51] PATHWAYS FOR THE MUTAGENESIS OF 1-NITROPYRENE AND DINITROPYRENES IN THE HUMAN HEPATOMA-CELL LINE HEPG2
    SILVERS, KJ
    EDDY, EP
    MCCOY, EC
    ROSENKRANZ, HS
    HOWARD, PC
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 195 - 200
  • [52] SIVARAJAH K, 1982, MOL PHARMACOL, V21, P133
  • [53] A biochemical approach to the problem of aging: "Megaproject" on membrane-penetrating ions. The first results and prospects
    Skulachev, V. P.
    [J]. BIOCHEMISTRY-MOSCOW, 2007, 72 (12) : 1385 - 1396
  • [54] Selective targeting of an antioxidant to mitochondria
    Smith, RAJ
    Porteous, CM
    Coulter, CV
    Murphy, MP
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (03): : 709 - 716
  • [55] Activation of NO donors in mitochondria:: Peroxidase metabolism of (2-hydroxyamino-vinyl)-triphenyl-phosphonium by cytochrome c releases NO and protects cells against apoptosis
    Stoyanovsky, Detcho A.
    Vlasova, Irina I.
    Belikova, Natalia A.
    Kapralov, Alexandr
    Tyurin, Vladimir
    Kagan, Valerian E.
    [J]. FEBS LETTERS, 2008, 582 (05) : 725 - 728
  • [56] Interactions of cardiolipin and lyso-cardiolipins with cytochrome c and tBid:: conflict or assistance in apoptosis
    Tyurin, V. A.
    Tyurina, Y. Y.
    Osipov, A. N.
    Belikova, N. A.
    Basova, L. V.
    Kapralov, A. A.
    Bayir, H.
    Kagan, V. E.
    [J]. CELL DEATH AND DIFFERENTIATION, 2007, 14 (04) : 872 - 875
  • [57] Oxidative lipidomics of γ-irradiation-induced intestinal injury
    Tyurina, Yulia Y.
    Tyurin, Vladimir A.
    Epperly, Michael W.
    Greenberger, Joel S.
    Kagan, Valerian E.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2008, 44 (03) : 299 - 314
  • [58] Mechanisms of cardiolipin oxidation by cytochrome c:: Relevance to pro- and antiapoptotic functions of etoposide
    Tyurina, Yulia Y.
    Kini, Vidisha
    Tyurin, Vladimir A.
    Vlasova, Irina I.
    Jiang, Jianfei
    Kapralov, Alexander A.
    Belikova, Natalia A.
    Yalowich, Jack C.
    Kurnikov, Igor V.
    Kagan, Valerian E.
    [J]. MOLECULAR PHARMACOLOGY, 2006, 70 (02) : 706 - 717
  • [59] Valianpour F, 2002, CLIN CHEM, V48, P1390
  • [60] VANDERZEE J, 1989, J BIOL CHEM, V264, P19828